BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBHST
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBioharvest Sciences Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 05, 2015
āļāļĩāļāļĩāđāļSobel (Ilan)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ- -
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļAug 05
āļāļĩāđāļāļĒāļđāđ1140 - 625 Howe Street
āđāļĄāļ·āļāļVANCOUVER
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻCanada
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđV6C 2T6
āđāļāļĢāļĻāļąāļāļāđ16046221186
āđāļ§āđāļāđāļāļāđhttps://bioharvest.com/about/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBHST
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 05, 2015
āļāļĩāļāļĩāđāļSobel (Ilan)
Mr. David K. (Dave) Ryan
Vice President - Investor Relations, Secretary
Vice President - Investor Relations, Secretary
Mr. David K. (Dave) Ryan
Vice President - Investor Relations, Secretary
Vice President - Investor Relations, Secretary
Dr. Yoheved (Yochi) Hagay, Ph.D.
Dr. Yoheved (Yochi) Hagay, Ph.D.
Chief Technology Officer
Dr. Yoheved (Yochi) Hagay, Ph.D.
Dr. Yoheved (Yochi) Hagay, Ph.D.
Chief Technology Officer
Ms. Anne Binder
Independent Director
Ms. Anne Binder
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. David K. (Dave) Ryan
Vice President - Investor Relations, Secretary
Vice President - Investor Relations, Secretary
Mr. David K. (Dave) Ryan
Vice President - Investor Relations, Secretary
Vice President - Investor Relations, Secretary